BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  NeuroVive Interim Report January - September 2017

  Net revenues were SEK 0 and other operating income was SEK 397,000.

  November 21, 2017

   · 

  3 min read
• Policy

  U.S. FDA Accepts Regulatory Submission and Grants Priority Review for U.S. WorldMeds’ Lofexidine

  During lofexidine’s development, the FDA granted it Fast Track Status, a process designed to facilitate and expedite the review of drugs to treat serious conditions and fill an unmet medical need.

  November 21, 2017

   · 

  3 min read
• Business

  Arcadia Biosciences Announces Kevin Comcowich Will Chair Board of Directors

  Comcowich replaces George Gosbee who passed away last week.

  November 21, 2017

   · 

  1 min read
• Drug Development

  Results From 282 Abstracts Including Celgene Therapies and Pipeline Compounds to Be Presented at the American Society of Hematology Annual Meeting (ASH)

  The presentations will focus on a wide range of disease areas including multiple myeloma, lymphoma, acute myeloid leukemia and more.

  November 21, 2017

   · 

  31 min read
• Matrix Analytics Releases LungDirect v3.0 With SmartFlow Feature and Other Upgrades

  Matrix Analytics releases Version 3.0 of its revolutionary pulmonary incidentaloma and lung screening management software.

  November 21, 2017

   · 

  2 min read
• Business

  Shineco Enters into RMB 1.12B Worth of Strategic Cooperation Agreement for Apocynum Industrial Park Projects in the Nationally Designated Economic Development Zone in Xinjiang, China

  Shineco will operate the Apocynum Industrial Park through Runze for apocynum fiber “Steam Explosion Degumming” manufacturing, apocynum comprehensive utilization as well as apocynum industry extension projects.

  November 21, 2017

   · 

  5 min read
• Symcel Secures €3.6 Million Horizon 2020 Phase II Grant for Clinical Validation of Customized Antimicrobial Susceptibility Testing Multi-Resistant Bacterial Sepsis Infections to be Validated Utilising Symcel’s Sensitive Screening Technology

  The project runs over 28 months with a consortium of internationally recognized academic and clinical key opinion leaders from Karolinska Institutet, Hospital Universitario Ramón y Cajal, Careggi University Hospital, Rigshospitalet, IHE and Symcel.

  November 21, 2017

   · 

  4 min read
• Heidelberg Pharma AG Raises Approximately EUR 34.4 Million From Capital Measure

  Heidelberg Pharma AG will receive gross issue proceeds of EUR 34,427,274 million from the corporate action, which will be used to finance the Company’s ATAC development programs.

  November 21, 2017

   · 

  3 min read
• Deals

  Avantor Completes Acquisition of VWR

  VWR will operate as a wholly-owned subsidiary of Avantor.

  November 21, 2017

   · 

  5 min read
• Business

  Nano Global, Arm Collaborate on Artificial Intelligence Chip to Drive Health Revolution by Capturing and Analyzing Molecular Data in Real Time

  The technology will help redefine how global health challenges - from superbugs to infectious diseases, and cancer are conquered.

  November 21, 2017

   · 

  3 min read